All News about Daiichi Sankyo Ltd ADR
![](https://investorplace.com/wp-content/uploads/2019/07/nasdaq-building-blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/27/MerckCo.png?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2024/05/28/Shanghai-china-feb-12th-2023-Astrazeneca.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/29/astrazeneca.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/aapharma_9.png?width=1200&height=800&fit=crop)
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/13/logo_en_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_21.png?width=1200&height=800&fit=crop)
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/AstraZeneca-HQ-in-Cambridge-UK_7.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Pfizer-shutterstock2_2.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/03/espr_co.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/japan-unsplash.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/752665/scientist-peers-in-microscope-in-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/22/azn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/11/azn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/21/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/03/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/03/azn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/27/psychedelics_deals_geralt_sergeitokmakov_by_pixabay_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/06/azn_logo_light__be17eab4ae088104f967b5a894607a0b.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/719491/investor-in-deep-thought-getty.jpg)
![](https://cdn.pixabay.com/photo/2014/12/10/20/48/medic-563425_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/azn_logo_light__be17eab4ae088104f967b5a894607a0b.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/800px-astrazeneca_hq_in_cambridge_uk.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_16.png?width=1200&height=800&fit=crop)
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/cheapstocks1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/15/aapharma_3.png?width=1200&height=800&fit=crop)
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/15/aapharma.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.